Get the Stockscreener App
5.29
0.38%
0.02
After Hours:
5.42
0.13
+2.46%
Salarius Pharmaceuticals Inc stock is traded at $5.29, with a volume of 46,906.
It is up +0.38% in the last 24 hours and down -35.88% over the past month.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
See More
Previous Close:
$5.27
Open:
$5.35
24h Volume:
46,906
Relative Volume:
0.21
Market Cap:
$2.70M
Revenue:
$4.70M
Net Income/Loss:
$-4.99M
P/E Ratio:
-0.824
EPS:
-6.42
Net Cash Flow:
$-5.29M
1W Performance:
+12.31%
1M Performance:
-35.88%
6M Performance:
-64.05%
1Y Performance:
-77.10%
1-Day Range:
$5.25
$5.4666
1-Week Range:
$4.50
$5.65
52-Week Range:
$4.50
$108.00
Salarius Pharmaceuticals Inc Stock (SLRX) Company Profile
Name
Salarius Pharmaceuticals Inc
Sector
Industry
Phone
346-772-0346
Address
2450 HOLCOMBE BLVD, HOUSTON
Compare SLRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLRX
Salarius Pharmaceuticals Inc
|
5.29 | 2.33M | 4.70M | -4.99M | -5.29M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Salarius Pharmaceuticals Inc Stock (SLRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-27-20 | Initiated | Ladenburg Thalmann | Buy |
Salarius Pharmaceuticals Inc Stock (SLRX) Latest News
How sentiment analysis helps forecast Salarius Pharmaceuticals Inc.Portfolio Performance Summary & Risk Controlled Swing Alerts - Newser
Analyzing Salarius Pharmaceuticals Inc. with risk reward ratio charts2025 Market Sentiment & Weekly High Return Opportunities - Newser
Key metrics from Salarius Pharmaceuticals Inc.’s quarterly dataQuarterly Performance Summary & High Yield Equity Trading Tips - Newser
Chart based analysis of Salarius Pharmaceuticals Inc. trendsJuly 2025 Macro Moves & Safe Entry Momentum Tips - Newser
How to integrate Salarius Pharmaceuticals Inc. into portfolio analysis toolsEarnings Overview Report & AI Powered Trade Plan Recommendations - Newser
What machine learning models say about Salarius Pharmaceuticals Inc.Weekly Investment Recap & Technical Analysis for Trade Confirmation - Newser
Will Salarius Pharmaceuticals Inc. outperform the marketMarket Trend Summary & Community Verified Trade Signals - Newser
Pattern recognition hints at Salarius Pharmaceuticals Inc. upsideTrade Volume Summary & Reliable Price Breakout Alerts - Newser
Salarius Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Intraday Action & AI Powered Buy and Sell Recommendations - Newser
Short interest data insights for Salarius Pharmaceuticals Inc.2025 Historical Comparison & AI Forecasted Entry/Exit Points - Newser
Using Python tools to backtest Salarius Pharmaceuticals Inc. strategies2025 Fundamental Recap & Daily Stock Momentum Reports - Newser
How to build a custom watchlist for Salarius Pharmaceuticals Inc.July 2025 Final Week & Reliable Volume Spike Trade Alerts - Newser
Technical signs of recovery in Salarius Pharmaceuticals Inc.July 2025 Decliners & Accurate Technical Buy Alerts - Newser
Visualizing Salarius Pharmaceuticals Inc. stock with heatmapsBreakout Watch & Verified High Yield Trade Plans - Newser
Is it time to cut losses on Salarius Pharmaceuticals Inc.2025 Top Gainers & Stepwise Trade Signal Implementation - Newser
Advanced analytics toolkit walkthrough for Salarius Pharmaceuticals Inc.Quarterly Market Summary & High Return Stock Watch Alerts - Newser
Using RSI to spot recovery in Salarius Pharmaceuticals Inc.Gap Up & Free Technical Confirmation Trade Alerts - Newser
Multi factor analysis applied to Salarius Pharmaceuticals Inc.Weekly Stock Summary & Weekly Market Pulse Alerts - Newser
What recovery options are there for Salarius Pharmaceuticals Inc.Exit Point & Fast Gaining Stock Strategy Reports - Newser
Sustainable product co. Iwi nabs $8M in growth capital | Salarius expands through acquisition - The Business Journals
Can Salarius Pharmaceuticals Inc. hit a new high this monthJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - Newser
Is a relief rally coming for Salarius Pharmaceuticals Inc. holdersMarket Growth Summary & Expert Curated Trade Ideas - Newser
What the charts say about Salarius Pharmaceuticals Inc. todayLong Setup & Free Technical Confirmation Trade Alerts - Newser
Using Ichimoku Cloud for Salarius Pharmaceuticals Inc. technicalsDollar Strength & High Yield Equity Trading Tips - Newser
Real time social sentiment graph for Salarius Pharmaceuticals Inc.Market Sentiment Report & Daily Volume Surge Signals - Newser
Using data filters to optimize entry into Salarius Pharmaceuticals Inc.2025 Top Gainers & High Win Rate Trade Tips - Newser
Is Salarius Pharmaceuticals Inc. stock entering bullish territoryOptions Play & High Accuracy Trade Signal Alerts - Newser
Is Salarius Pharmaceuticals Inc. meeting your algorithmic filter criteriaExit Point & High Win Rate Trade Alerts - Newser
Can trapped investors hope for a rebound in Salarius Pharmaceuticals Inc.2025 Market Outlook & Risk Managed Investment Strategies - Newser
Salarius Pharmaceuticals regains compliance with Nasdaq minimum bid price requirement - MSN
Salarius Pharmaceuticals Regains Nasdaq Compliance with Minimum Bid Price Requirement - Quiver Quantitative
Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire
Biotech Salarius Regains Nasdaq Compliance While Pursuing Merger with Decoy Therapeutics - Stock Titan
Will Salarius Pharmaceuticals Inc. stock go up soonMarket Sentiment Report & AI Forecast Swing Trade Picks - Newser
Smart tools for monitoring Salarius Pharmaceuticals Inc.’s price actionBull Run & Smart Allocation Stock Tips - Newser
Salarius Pharmaceuticals Inc Stock (SLRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):